Stage FocusSeed, Series A
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedTechSynthetic Biology
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Third Rock Ventures was founded in 2007 by Kevin Starr, Mark Levin, and Robert Tepper, all former executives at Millennium Pharmaceuticals. The firm has raised $3.8B in total, including a $1.1B Fund VI in 2022, and was ranked the #1 biotech VC by STAT for returns.
The model is "Discover. Launch. Build. Transform." — Third Rock builds companies from scratch rather than simply investing in existing...
Notable Investments
R
Relay TherapeuticsB
Blueprint MedicinesF
Foundation MedicineF
Fulcrum TherapeuticsA
AgiosB
Bluebird BioSimilar Funds
ARCH Venture Partners
Chicago, United States
Pure DeepTechBiotechMedTechSynthetic BiologySeedSeries A
Atlas Venture
Cambridge, United States
Pure DeepTechBiotechSynthetic BiologyMedTechSeedSeries A
Bold Capital Partners
Santa Monica, United States
Pure DeepTechBiotechAI InfrastructureMedTechSeedSeries A
Civilization Ventures
San Francisco, United States
DeepTech NativeBiotechSynthetic BiologyAI InfrastructureSeedSeries A
Longwood Fund
Boston, United States
Pure DeepTechBiotechMedTechPre-SeedSeed
Seroba Life Sciences
Dublin, Ireland
Pure DeepTechBiotechMedTechSeedSeries A